A new digital health hub at UCL backed by the BRC will bring together a team to better deploy digital technologies in the fight against antimicrobial resistance across humans, animals and the environment.
Quell Therapeutics, a UCL spinout that develops cell engineering technology to treat autoimmune diseases, is to collaborate with biopharmaceutical giant AstraZeneca in a deal worth over $2billion (£1.6bn).
Lesbian, gay and bisexual people are more than twice as likely than their straight peers to experience suicidal thoughts or self-harming behaviours, finds a new study led by UCL researchers.
Research has identified a new compound that can stimulate nerve regeneration after injury, as well as protect cardiac tissue from the sort of damage seen in heart attack.
An innovative new study at UCLH is investigating the feasibility of delivering a clinical trial in routine care using the electronic health record system.
Dr Catherine Mummery has been announced as the new Chair of the National Institute for Health and Care Research Dementia Translational Research Collaboration.
